论文信息 - LBA34 Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials - 字舞流文

LBA34 Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials

B. Monk | D. Berton | I. Bondarenko | I. Ray-Coquard | A. Leary | M. Ancukiewicz | F. Selle | I. Lugowska | A. Oaknin | L. Gladieff | D. O’Malley | T. Meniawy | J. Alexandre | C. Rojas | L. Randall | K. Moore | A. Kryzhanivska | I. Shapiro | W. O. Feliu | M. Neffa | I. Lugowska